These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Active immunotherapy of cancer for minimal residual disease: new trends and new materials. Mathé G, Florentin I, Olsson L, Kiger N, Bruley-Rosset M, Orbach-Arbouys S, Schulz JI. Prog Exp Tumor Res; 1980 Sep; 25():242-74. PubMed ID: 6986635 [No Abstract] [Full Text] [Related]
19. A randomized study of adjuvant immunotherapy with levamisole and Corynebacterium parvum in operable non-small cell lung cancer. Fox RM, Woods RL, Tattersall MH, Basten A. Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1043-5. PubMed ID: 6998933 [No Abstract] [Full Text] [Related]